QR code

Effect of Anagliptin versus Sitagliptin on Inflammatory Markers: Sub-Analysis from the REASON Trial

Hiroki Teragawa,1 Takeshi Morimoto,2 Yuichi Fujii,1 Tomohiro Ueda,1 Mio Sakuma,2 Michio Shimabukuro,3 Osamu Arasaki,4 Koichi Node,5 Takashi Nomiyama,6 Shinichiro Ueda7 1Department of Cardiovascular Medicine, JR Hiroshima Hospital, Hiroshima, Japan; 2Department of Clinical Epidemiology, Hyogo College...

Volledige beschrijving

Bewaard in:
Hoofdauteurs: Teragawa H, Morimoto T, Fujii Y, Ueda T, Sakuma M, Shimabukuro M, Arasaki O, Node K, Nomiyama T, Ueda S
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Dove Medical Press 2020-12-01
Reeks:Diabetes, Metabolic Syndrome and Obesity
Onderwerpen:
c-reactive protein
dipeptidylpeptidase-4
dpp-4 inhibitor
inflammation
interleukin-6
white blood cell
Online toegang:https://www.dovepress.com/effect-of-anagliptin-versus-sitagliptin-on-inflammatory-markers-sub-an-peer-reviewed-article-DMSO
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items